XML 38 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Supplemental Financial Information
 12 Months Ended
Dec. 31, 2022
Supplemental Financial Information [Abstract]  
Additional Financial Information Disclosure [Text Block] Supplemental Financial Information
Balance Sheet
202220212020
Accounts and notes receivable (a)
Trade receivables$8,192 $7,172 
Other receivables2,121 1,655 
Total10,313 8,827 
Allowance, beginning of year147 201 $105 
Cumulative effect of accounting change— — 44 
Net amounts charged to expense (b)
21 (19)79 
Deductions (c)
(12)(25)(32)
Other (d)
(6)(10)5 
Allowance, end of year150 147 $201 
Net receivables$10,163 $8,680 
Inventories (e)
Raw materials and packaging $2,366 $1,898 
Work-in-process114 151 
Finished goods2,742 2,298 
Total$5,222 $4,347 
Property, plant and equipment, net (f)
Average
Useful Life (Years)
Land $1,142 $1,123 
Buildings and improvements
15 - 44
10,816 10,279 
Machinery and equipment, including fleet and software
5 - 15
33,335 31,486 
Construction in progress4,491 3,940 
49,784 46,828 
Accumulated depreciation(25,493)(24,421)
Total$24,291 $22,407 
Depreciation expense$2,523 $2,484 $2,335 
Other assets
Noncurrent notes and accounts receivable$202 $111 
Deferred marketplace spending123 119 
Pension plans (g)
948 1,260 
Right-of-use assets (h)
2,373 2,020 
Other investments (i)
813 277 
Other833 694 
Total$5,292 $4,481 
Accounts payable and other current liabilities
Accounts payable (j)
$10,732 $9,834 
Accrued marketplace spending3,637 3,087 
Accrued compensation and benefits2,519 2,324 
Dividends payable1,610 1,508 
Current lease liabilities (h)
483 446 
Other current liabilities 4,390 3,960 
Total$23,371 $21,159 
(a)Increase primarily reflects strong revenue performance across much of our portfolio in 2022.
(b)2021 includes reductions in allowance for expected credit losses related to COVID-19 pandemic recorded in 2020.
(c)Includes accounts written off.
(d)Includes adjustments related primarily to currency translation and other adjustments.
(e)Increase reflects higher commodity costs in 2022. Approximately 9% and 7% of the inventory cost in 2022 and 2021, respectively, were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material. See Note 2 for further information.
(f)See Note 2 for further information.
(g)See Note 7 for further information.
(h)See Note 12 for further information.
(i)Increase in 2022 primarily reflects our investment in Celsius convertible preferred stock. See Note 9 for further information.
(j)Increase reflects higher commodity costs and capital expenditures in 2022.
Statement of Cash Flows
202220212020
Interest paid (a)
$1,043 $1,184 $1,156 
Income taxes paid, net of refunds (b)
$2,766 $1,933 $1,770 
(a)2022 excludes the premiums paid in accordance with the debt transactions. 2021 excludes the charge related to cash tender offers. See Note 8 for further information.
(b)In 2022, 2021 and 2020, includes tax payments of $309 million, $309 million and $78 million, respectively, related to the TCJ Act.
The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement.
20222021
Cash and cash equivalents$4,954 $5,596 
Restricted cash included in other assets (a)
146 111 
Total cash and cash equivalents and restricted cash$5,100 $5,707 
    
(a)Primarily relates to collateral posted against certain of our derivative positions.